Sequana Medical raises Series C

Sequana Medical has raised CHF 23 million ($26.2 million) in a Series C preferred share financing round led by Life Science Partners and co-led by NeoMed Management, VI Partners, BioMedInvest, Entrepreneurs Fund and Capricorn Venture Partners. The business is a Swiss medical device company.

28 April 2014•5 mins read
Feature image
LinkedInXEmail
LinkedInXEmail